Exposure to a common herbicide may increase the risk of a rare congenital disorder, according to a new study. Researchers at Baylor College of Medicine found that exposure to atrazine – the most commonly used herbicide in the U.S. – may be linked to an increased risk of choanal atresia. Atrazine is typically used in corn crops.
Read more about the link between atrazine and birth defects...
October 24, 2012
Forest Laboratories files for FDA approval of new antidepressant drug
Forest Laboratories has filed for marketing approval from the Food and Drug Administration (FDA) for its new antidepressant drug levomilnacipran, which is in the same class of drugs as the antidepressant Effexor. The drugs are classified as serotonin norepinephrine reuptake inhibitors (SNRIs).
Read more about new SNRI antidepressant...
Read more about new SNRI antidepressant...
October 11, 2012
Montana parents suing drug company over daughter’s birth defects
The Montana parents of a baby born with a serious heart defect are suing a pharmaceutical company and others claiming that the antidepressant Effexor XR caused the defect.The lawsuit names Wyeth Pharmaceuticals Inc., Pfizer Inc., CVS Pharmacy, Caremark RX and Montana CVS Pharmacy as defendants.
October 2, 2012
Drug maker receives approval for generic Lexapro
Indian drug maker Lupin Pharmaceuticals has received final approval from the Food and Drug Administration to sell its generic form of the antidepressant Lexapro in the U.S. The company is among the first to receive approval.
October 1, 2012
SSRIs among most-prescribed drugs in 2011 despite birth defect risks
Antidepressant drugs in a class known as selective serotonin reuptake inhibitors (SSRIs) were among the most-prescribed drugs in 2011, despite warnings of potentially serious side effects. Celexa and Zoloft topped the list of SSRI antidepressants prescribed, which totaled more than 264 million.
Subscribe to:
Posts (Atom)